Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life
| Status: | Completed |
|---|---|
| Conditions: | Blood Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 1/13/2018 |
| Start Date: | October 2012 |
| End Date: | June 2016 |
Prospective Assessment of Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life
We are interested in studying whether and how medical problems other than primary cancer
before hematopoietic cell transplantation would impact the profiles of quality of life and
toxicities post-transplantation for patients with blood cancers. We want to see if by
assessing comorbidities (such as diabetes) early on, we can identify those patients who will
have more toxicities or limitations in their quality of life after transplant. The generated
information could set the stage for future intervention studies aiming to improve quality of
life for patients with blood cancers after transplantation.
before hematopoietic cell transplantation would impact the profiles of quality of life and
toxicities post-transplantation for patients with blood cancers. We want to see if by
assessing comorbidities (such as diabetes) early on, we can identify those patients who will
have more toxicities or limitations in their quality of life after transplant. The generated
information could set the stage for future intervention studies aiming to improve quality of
life for patients with blood cancers after transplantation.
Inclusion Criteria:
- Allogeneic HCT candidates who are >18 years of age
- Able to speak and read English
- Able to provide informed consent
- Access to a telephone for study-related communications
- Diagnosed with a hematological malignant disease
- Willing to complete survey packets at 5 time-points, spanning two years
Exclusion Criteria:
- HCT candidates who are 18 years or younger at the time of study enrollment
- HCT candidates who cannot read, write, or speak English
- Patients with diagnoses of non-malignant diseases, or solid tumors are primary disease
We found this trial at
1
site
1100 Fairview Avenue North
Seattle, Washington 98109
Seattle, Washington 98109
(206) 667-5000
Fred Hutchinson Cancer Research Center At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of...
Click here to add this to my saved trials
